Now Available: Huntington's Disease - Pipeline Assessment and Market Forecasts to 2017

Dec. 28, 2010 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Huntington's Disease - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Huntington's disease therapeutics market and pipeline. The report identifies the key trends shaping and driving the global huntington's disease therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global muscular dystrophy therapeutics sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData has estimated the global Huntington's disease therapeutics market to be valued at $142 m in 2009. It is expected to increase to $2 billion with a Compound Annual Growth Rate (CAGR) of 39.6 by 2017. There is a high unmet need in the current Huntington's disease therapeutics market in terms of both safety and efficacy profile. New high potential drugs of Huntington's disease therapeutics are expected to come in the market after 2017.

Scope

The report provides information on the key drivers and challenges of the Huntington's disease therapeutics market. Its scope includes:  

* Annualized global Huntington's disease therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major classes such as nerve growth factor and doparmegenic neurons loss inhibitor
* Analysis of the current and future competition in the global Huntington's disease therapeutics market. Key market players covered are Amarin Corporation and Medivation Inc.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Huntington's disease therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Huntington's disease therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Huntington's disease market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Huntington's disease market landscape? - Identify, understand and capitalize.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/103792_huntingtons_disease_pip...


Partial Table of Contents:

1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Huntington's Disease: Market Characterization 5
2.1 Overview 5
2.2 Huntington's Disease Therapeutics Market Size 6
2.3 Huntington's Disease Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Huntington's Disease Therapeutics Market 8
2.4.1 Drivers for the Huntington's Disease Therapeutics Market 8
2.4.2 Barriers for the Huntington's Disease market 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 10
3 Huntington's Disease Therapeutics Market: Competitive Assessment 11
3.1 Overview 11
3.2 Strategic Competitor Assessment 11
3.3 Product Profile for the Major Marketed Products in the Huntington's Disease Therapeutics Market 12
3.3.1 Xenazine (tetrabenazine) 12
3.4 Key Takeaway 13
4 Huntington's Disease: Pipeline Assessment 14
4.1 Overview 14
4.2 Strategic Pipeline Assessment 14
4.2.1 Technology Trends Analytic Framework 14
4.3 Huntington's Disease Therapeutics - Promising Drugs under Clinical Development 16
4.4 Molecule Profile for Promising Drugs under Clinical Development 17
4.4.1 AMR-101 (Miraxion, ethyl EPA) (Amarin Pharmaceuticals) 17
4.4.2 Dimebon (latrepirdine) (Medivation/Pfizer) 18
4.4.3 Coenzyme Q10 (CoQ) (National Institute of Neurological Disorders and Stroke - NINDS) 19
4.5 Huntington's Disease Therapeutics- Clinical Pipeline by Mechanism of Action 20
4.5.1 Huntington's Disease TherapeuticsPipeline - Pipeline by Clinical Phases of Development 21
4.5.2 Huntington's Disease Therapeutics - Phase III Clinical Pipeline 21
4.5.3 Huntington's Disease Therapeutics - Phase II Clinical Pipeline 21
4.5.4 Huntington's Disease Therapeutics - Phase I Clinical Pipeline 22
4.5.5 Huntington's Disease Therapeutics - Preclinical Phase Pipeline 22
4.5.6 Huntington's Disease Therapeutics - Discovery Pipeline 22
4.6 Key Takeaway 23
5 Huntington's Disease Therapeutics Market: Implications for Future Market Competition 24
6 Huntington's Disease Therapeutics Market: Future Players in the Huntington's Disease Market 26
6.1 Introduction 26
6.2 Amarin Corporation, Ireland 27
6.2.1 Overview 27
6.2.2 CNS Portfolio 27
6.2.3 Huntington's disease Portfolio 27
6.3 Medivation Inc., the US 28
6.3.1 Overview 28
6.3.2 CNS Portfolio 29
6.3.3 Huntington's Disease Portfolio 29

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1037...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.